scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "Abani, Obbina"

1 - 4 of 4 results for
 "Abani, Obbina"
Results per page:

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Publication Type: Periodical

Source(s): The Lancet; February 2022, Vol. 399 Issue: 10325 p665-676, 12p

Abstract: Casirivimab and imdevimab are non-competing monoclonal antibodies that bind to two different sites on the receptor binding domain of the SARS-CoV-2 spike glycoprotein, blocking viral entry into host cells. We aimed to evaluate the efficacy and safety o...

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Publication Type: Periodical

Source(s): The Lancet; January 2022, Vol. 399 Issue: 10320 p143-151, 9p

Abstract: Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients admitted to hospital with COVID-19.

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Publication Type: Periodical

Source(s): The Lancet; May-June 2021, Vol. 397 Issue: 10289 p2049-2059, 11p

Abstract: Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19.

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Publication Type: Periodical

Source(s): The Lancet; May 2021, Vol. 397 Issue: 10285 p1637-1645, 9p

Abstract: In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation.

sponsored